Neuroscience
Brain
100%
Placebo
70%
Neurotransmitter
69%
Antipsychotic
60%
Risperidone
51%
Depression
45%
Serotonergic
38%
Dopaminergic
38%
Cognitive Disorders
38%
Magnetic Resonance Imaging
38%
Dementia Praecox
36%
Cognitive Flexibility
30%
Phosphodiesterase
30%
Ketamine
30%
Traumatic Brain Injury
30%
White Matter
30%
Dopamine Receptor D2
30%
Working Memory
30%
N-Back
30%
Roflumilast
30%
Eicosanoid Receptor
28%
Cognitive Function
24%
Parkinson's Disease
22%
Magnetic Resonance Imaging
19%
Dopamine
18%
Positron Emission Tomography
17%
Functional Magnetic Resonance Imaging
16%
Crossover Study
16%
Arterial Spin Labeling
14%
Antidepressant
13%
Executive Functions
13%
Ventral Tegmental Area
13%
Brain Areas
13%
Dorsolateral Prefrontal Cortex
12%
Functional Magnetic Resonance Imaging
12%
In Vivo
11%
D2 Antagonists
10%
Memory
9%
Glucopyranosyl Lipid A
8%
Predictor
8%
Neurotransmission
7%
Neurotransmitter Receptor
7%
Neurodegeneration
7%
Information Processing
6%
Putamen
6%
Dorsal Striatum
6%
Ventral Striatum
6%
Amygdala
6%
Nucleus Accumbens
6%
Olanzapine
6%
Medicine and Dentistry
Patient
61%
Functional Magnetic Resonance Imaging
35%
Ketamine
30%
Depression
30%
Inpatient
30%
Roflumilast
30%
Magnetic Resonance Imaging
30%
Spontaneous Remission
30%
Nuclear Imaging
30%
Phosphodiesterase IV Inhibitor
30%
Neurotransmitter
30%
Flexibility
30%
Dopamine Agonist
22%
Parkinson's Disease
22%
Placebo
20%
Brain Blood Flow
15%
Risperidone
15%
Anticipation
10%
Symptom
10%
Infusion
10%
Glucopyranosyl Lipid A
8%
Dorsolateral Prefrontal Cortex
8%
Amaurosis
7%
Acid
7%
Neurotransmission
7%
Receptor
7%
Neuroimaging
7%
Association
7%
Dopaminergic System
7%
Neurodegeneration
7%
Chemotherapeutic Agent
7%
Drug
7%
Feedback System
6%
Methadone
6%
Antidepressant
6%
Drug Effect
6%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
43%
Risperidone
30%
Antipsychotic
30%
Normal Human
30%
Dopamine Receptor D2
30%
Dopamine
18%
Messenger RNA
17%
Receptor
13%
Study Design
12%
Placebo
12%
Antagonist
10%
Drug Action
6%
Blindness
6%